Search Results - "vaccination"

Cancer vaccines part 1 of 2 /

Table of Contents: “…Contents: The hallmarks of cancer -- Categories of cancer-associated antigens -- Viral & non-viral cancers: vaccine targets -- Immunotherapeutics -- Immunologic reagents approved for cancer therapy -- Clinical outcome based on immune response -- CTL-based therapy -- Virus-specific CTL adoptive transfer therapy -- Immunotherapy for Melanoma.…”
Get full text
Series (Immunotherapy of cancer)
Series (Vaccines)

Vaccine adjuvants part 1 of 2 /

Table of Contents: “…Contents: Overview of vaccine adjuvants -- First generation particles -- Alum adjuvants -- MF59 adjuvant -- Polylactide co-glycolide particles.…”
Get full text
Series

Vaccine adjuvants part 2 of 2 /

Subjects: Get full text
Series

Animal vaccines basic principles /

Table of Contents: “…Contents: Passive immunization -- Active immunization -- Inactivated vaccines -- Living vaccines -- DNA plasmid vaccines -- Adjuvants.…”
Get full text

RSV vaccine development

Table of Contents: “…Contents: Many obstacles hinder RSV vaccine development -- Disease at extremes of age -- History of disease potentiation with formalin-inactivated RSV vaccine -- Various strategies for vaccine development -- RSV F subunit vaccine -- Maternal immunization -- Immunization of the elderly -- Live-attenuated and/or live-vectored vaccines -- Immunization of infants and children.…”
Get full text
Series

Dengue vaccine development l. Status /

Table of Contents: “…Contents: Scope of the dengue problem -- Assessing the need for a tetravalent vaccine -- In-depth look at current vaccines and their development status.…”
Get full text
Series

HIV vaccine development

Table of Contents: “…Contents: HIV virus biology and immune mechanisms -- Development of an HIV vaccine & accompanying difficulties -- New methods of vaccine development -- The ideal HIV vaccine -- HIV vaccine efficacy trials.…”
Get full text
Series

Bacterial vaccines in development part 1 of 2 /

Table of Contents: “…Contents: New bacterial vaccines in clinical development -- Phases of vaccine development -- Principles of vaccine antigen discovery & validation -- Novel vaccines in development for Gram+ pathogens: C. difficile.…”
Get full text
Series

Bacterial vaccines in development part 2 of 2 /

Table of Contents: “…Contents: Novel vaccines for Gram+ pathogens: S. aureus -- Novel vaccines for Gram- pathogens N. meningitides serogroup B.…”
Get full text
Series

Vaccine preclinical studies part 2 of 2 /

Table of Contents: “…Contents: Vaccine pharmacology -- Vaccine immunogenicity -- Vaccine challenge-protection studies.…”
Get full text
Series

Successes and failures with vaccines

Table of Contents: “…Contents: New strategies for vaccine development -- Influenza vaccines need improvement -- The microbiome influences rotavirus vaccine efficacy -- Vaccines against cytomegalovirus -- Vaccines against human papillomavirus and cervical cancer -- Insights from structural biology and the development of vaccines against respiratory syncytial virus -- Vaccines based on DNA and RNA.…”
Get full text
Series

Comparison of immune resilience induced by vaccination versus COVID recovery

Table of Contents: “…Contents: The need to characterize vaccine-indued immunity in more detail -- Methods for comparison of convalescent versus vaccination-induced plasma -- Higher effectiveness of antibodies induced by mRNA vaccination -- Characteristics of the new lambda variant – implications for immune escape -- Mechanisms leading to the increased efficiency of vaccine-induced antibodies compared to those of recovered patients..…”
Get full text
Series

Adenovirus vectors and vaccine responses

Subjects: Get full text

SARS-COV-2 vaccine development where are we now? /

Table of Contents: “…Contents: Vaccine development for SARS-COV-2: Current position -- Different types of potential vaccines against COVID-19 -- New technologies and their implications -- How past experience can support current research.…”
Get full text
Series

Immune response and rational development of vaccines and biomarkers

Table of Contents: “…Contents: Tuberculosis (TB), immune response and vaccine development -- TB: a major health threat -- T lymphocytes as central mediators of immunity in TB -- Rational design of novel vaccines against TB -- Characterization of biomarkers for TB vaccine trials.…”
Get full text
Series

Vaccines as a weapon against antibiotic resistance

Table of Contents: “…Contents: Overview of antibiotic resistance -- WHO Global Action Plan against resistance -- WHO's prioritization of pathogens -- Research discovery against new antibiotics -- Vaccines to combat antibiotic resistance -- Vaccine development against selected WHO prioritized pathogens.…”
Get full text
Series

SARS-CoV-2 vaccine development

Table of Contents: “…Contents: Current efforts to develop a vaccine -- Possible strategies for vaccine development -- Possible seasonal variations in virus prevalence -- When could a viable vaccine be expected?.…”
Get full text
Series

The development of SARS-CoV-2 vaccines

Table of Contents: “…Contents: Overview of three SARS-CoV-2 vaccines being developed -- Technologies being used -- Manufacturability -- Current stage of testing -- Next steps.…”
Get full text
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Table of Contents: “…Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".…”
Get full text
Series

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Table of Contents: “…Contents: The frequency of clotting side-effects in COVID-19 vaccines -- The characteristics of these side-effects and how they compare to other clotting disorders -- What is known regarding the mechanisms underlying these side effects -- What is known regarding populations at greater risk of suffering these side effects.…”
Get full text
Series